treatment of neurotrophic keratitis (NK)
All entries for: Mimetogen Pharmaceuticals Inc.
July 14, 2026
Mimetogen Pharmaceuticals Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of neurotrophic keratitis (NK)